The metal ion-promoted hydrolysis of the doxorubicin cardioprotective agent dexrazoxane (ICRF-187) has been studied by HPLC and spectrophotometrically. Dexrazoxane is thought to be cardioprotective through the ability of its rings-opened hydrolysis product (D) to chelate loosely bound iron, thus preventing iron-based oxygen free radical damage. While neither Mg(II) nor Ca(II) promoted the hydrolysis of the opening of the first dexrazoxane ring, Zn(II) strongly promoted (60-fold) hydrolysis. However, physiological concentrations of Mg(II) and Ca(II) promoted hydrolysis of the one-ring open dexrazoxane hydrolysis intermediates (B and C) by up to 18-fold. Thus, Mg(II) and Ca(II) may be, in part, responsible for mediating the formation of the active metal ion-chelating form of the drug in vivo. A variety of other metal ions (Mn(II), Co(II), Ni(II), Cu(II) and Zn(II)) strongly promoted hydrolysis of B and C by factors ranging from 25 for Mn(II), to greater than 50,000 for Zn(II) and Cu(II). The Zn(II)-promoted hydrolysis of B and C showed a strong pH dependence, which may be due either to a hydroxide bound to Zn(II) or free hydroxide in solution acting as a nucleophile. Titration of the Fe(III)-B and Fe(III)-D complex with azide resulted in spectral changes consistent with formation of ternary complexes, indicating that these complexes have open or loosely bound coordination sites.
Read full abstract